Genotype study makes its point

Data published in Nature Genetics by scientists at Genset S.A. (Paris, France) and partner Abbott Laboratories (Abbott Park, Ill.) suggests a predictive role for the ALOX5 genotype in managing asthma.

The research effectively shows proof of principle for the pharmacogenomics strategy of analyzing the effects of genetic variations on patient response